nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Irinotecan—colon cancer	0.0867	0.384	CbGbCtD
Vardenafil—CYP3A5—Vincristine—colon cancer	0.0758	0.336	CbGbCtD
Vardenafil—CYP3A4—Irinotecan—colon cancer	0.0338	0.15	CbGbCtD
Vardenafil—CYP3A4—Vincristine—colon cancer	0.0296	0.131	CbGbCtD
Vardenafil—PDE11A—epithelium—colon cancer	0.0211	0.129	CbGeAlD
Vardenafil—PDE5A—endothelium—colon cancer	0.0179	0.109	CbGeAlD
Vardenafil—PDE5A—blood vessel—colon cancer	0.0165	0.101	CbGeAlD
Vardenafil—PDE11A—liver—colon cancer	0.012	0.0731	CbGeAlD
Vardenafil—PDE6G—liver—colon cancer	0.0115	0.0703	CbGeAlD
Vardenafil—PDE10A—digestive system—colon cancer	0.0104	0.0638	CbGeAlD
Vardenafil—PDE6G—lymph node—colon cancer	0.00883	0.0539	CbGeAlD
Vardenafil—PDE5A—epithelium—colon cancer	0.00803	0.049	CbGeAlD
Vardenafil—PDE5A—smooth muscle tissue—colon cancer	0.00774	0.0473	CbGeAlD
Vardenafil—PDE5A—renal system—colon cancer	0.00745	0.0455	CbGeAlD
Vardenafil—PDE5A—digestive system—colon cancer	0.00611	0.0373	CbGeAlD
Vardenafil—PDE10A—lymph node—colon cancer	0.00596	0.0364	CbGeAlD
Vardenafil—PDE1B—lymph node—colon cancer	0.00591	0.0361	CbGeAlD
Vardenafil—PDE5A—vagina—colon cancer	0.0054	0.0329	CbGeAlD
Vardenafil—PDE5A—lymph node—colon cancer	0.00349	0.0213	CbGeAlD
Vardenafil—CYP3A5—renal system—colon cancer	0.00309	0.0189	CbGeAlD
Vardenafil—CYP3A5—digestive system—colon cancer	0.00254	0.0155	CbGeAlD
Vardenafil—CYP3A4—renal system—colon cancer	0.00232	0.0142	CbGeAlD
Vardenafil—CYP3A5—vagina—colon cancer	0.00224	0.0137	CbGeAlD
Vardenafil—Sinusitis—Fluorouracil—colon cancer	0.00198	0.0036	CcSEcCtD
Vardenafil—Haemorrhage—Irinotecan—colon cancer	0.00198	0.0036	CcSEcCtD
Vardenafil—Connective tissue disorder—Irinotecan—colon cancer	0.00195	0.00354	CcSEcCtD
Vardenafil—Visual impairment—Irinotecan—colon cancer	0.00191	0.00347	CcSEcCtD
Vardenafil—Haemoglobin—Fluorouracil—colon cancer	0.00191	0.00347	CcSEcCtD
Vardenafil—CYP3A4—digestive system—colon cancer	0.0019	0.0116	CbGeAlD
Vardenafil—Rhinitis—Fluorouracil—colon cancer	0.0019	0.00346	CcSEcCtD
Vardenafil—Haemorrhage—Fluorouracil—colon cancer	0.0019	0.00345	CcSEcCtD
Vardenafil—CYP3A5—liver—colon cancer	0.00189	0.0115	CbGeAlD
Vardenafil—Cardiac disorder—Vincristine—colon cancer	0.00189	0.00343	CcSEcCtD
Vardenafil—Hypoaesthesia—Fluorouracil—colon cancer	0.00189	0.00343	CcSEcCtD
Vardenafil—Pharyngitis—Fluorouracil—colon cancer	0.00188	0.00342	CcSEcCtD
Vardenafil—Face oedema—Capecitabine—colon cancer	0.00185	0.00336	CcSEcCtD
Vardenafil—Angiopathy—Vincristine—colon cancer	0.00184	0.00335	CcSEcCtD
Vardenafil—Cardiac disorder—Irinotecan—colon cancer	0.00184	0.00334	CcSEcCtD
Vardenafil—Flushing—Irinotecan—colon cancer	0.00184	0.00334	CcSEcCtD
Vardenafil—Mediastinal disorder—Vincristine—colon cancer	0.00183	0.00333	CcSEcCtD
Vardenafil—Angiopathy—Irinotecan—colon cancer	0.0018	0.00327	CcSEcCtD
Vardenafil—Blood creatinine increased—Capecitabine—colon cancer	0.00179	0.00326	CcSEcCtD
Vardenafil—Immune system disorder—Irinotecan—colon cancer	0.00179	0.00325	CcSEcCtD
Vardenafil—Mediastinal disorder—Irinotecan—colon cancer	0.00178	0.00324	CcSEcCtD
Vardenafil—Mental disorder—Vincristine—colon cancer	0.00178	0.00324	CcSEcCtD
Vardenafil—Liver function test abnormal—Capecitabine—colon cancer	0.00177	0.00322	CcSEcCtD
Vardenafil—Orthostatic hypotension—Capecitabine—colon cancer	0.00175	0.00318	CcSEcCtD
Vardenafil—Abdominal pain upper—Capecitabine—colon cancer	0.00175	0.00318	CcSEcCtD
Vardenafil—Breast disorder—Capecitabine—colon cancer	0.00173	0.00315	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00172	0.00314	CcSEcCtD
Vardenafil—Back pain—Vincristine—colon cancer	0.00171	0.00311	CcSEcCtD
Vardenafil—Gastritis—Capecitabine—colon cancer	0.0017	0.00308	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00169	0.00307	CcSEcCtD
Vardenafil—Back pain—Irinotecan—colon cancer	0.00167	0.00303	CcSEcCtD
Vardenafil—Muscle spasms—Irinotecan—colon cancer	0.00166	0.00301	CcSEcCtD
Vardenafil—Dysphagia—Capecitabine—colon cancer	0.00166	0.00301	CcSEcCtD
Vardenafil—Influenza—Capecitabine—colon cancer	0.00166	0.00301	CcSEcCtD
Vardenafil—Erythema—Fluorouracil—colon cancer	0.00165	0.003	CcSEcCtD
Vardenafil—Angina pectoris—Capecitabine—colon cancer	0.00161	0.00293	CcSEcCtD
Vardenafil—Ill-defined disorder—Irinotecan—colon cancer	0.0016	0.00291	CcSEcCtD
Vardenafil—Vertigo—Vincristine—colon cancer	0.00159	0.00289	CcSEcCtD
Vardenafil—Vision blurred—Fluorouracil—colon cancer	0.00156	0.00283	CcSEcCtD
Vardenafil—Malaise—Irinotecan—colon cancer	0.00155	0.00283	CcSEcCtD
Vardenafil—Vertigo—Irinotecan—colon cancer	0.00155	0.00282	CcSEcCtD
Vardenafil—Syncope—Irinotecan—colon cancer	0.00155	0.00281	CcSEcCtD
Vardenafil—Convulsion—Vincristine—colon cancer	0.00153	0.00279	CcSEcCtD
Vardenafil—Loss of consciousness—Irinotecan—colon cancer	0.00151	0.00275	CcSEcCtD
Vardenafil—Photosensitivity reaction—Capecitabine—colon cancer	0.00151	0.00275	CcSEcCtD
Vardenafil—Myalgia—Vincristine—colon cancer	0.00151	0.00274	CcSEcCtD
Vardenafil—Visual disturbance—Methotrexate—colon cancer	0.0015	0.00274	CcSEcCtD
Vardenafil—Infestation NOS—Capecitabine—colon cancer	0.00148	0.00268	CcSEcCtD
Vardenafil—Infestation—Capecitabine—colon cancer	0.00148	0.00268	CcSEcCtD
Vardenafil—Acute coronary syndrome—Capecitabine—colon cancer	0.00146	0.00265	CcSEcCtD
Vardenafil—Discomfort—Irinotecan—colon cancer	0.00145	0.00264	CcSEcCtD
Vardenafil—Myocardial infarction—Capecitabine—colon cancer	0.00145	0.00263	CcSEcCtD
Vardenafil—Anaphylactic shock—Vincristine—colon cancer	0.00144	0.00263	CcSEcCtD
Vardenafil—Infection—Vincristine—colon cancer	0.00144	0.00261	CcSEcCtD
Vardenafil—Conjunctivitis—Capecitabine—colon cancer	0.00143	0.00261	CcSEcCtD
Vardenafil—Convulsion—Fluorouracil—colon cancer	0.00143	0.0026	CcSEcCtD
Vardenafil—CYP3A4—liver—colon cancer	0.00142	0.00867	CbGeAlD
Vardenafil—Nervous system disorder—Vincristine—colon cancer	0.00142	0.00258	CcSEcCtD
Vardenafil—Haematuria—Capecitabine—colon cancer	0.00141	0.00256	CcSEcCtD
Vardenafil—Anaphylactic shock—Irinotecan—colon cancer	0.00141	0.00256	CcSEcCtD
Vardenafil—Chest pain—Fluorouracil—colon cancer	0.00141	0.00256	CcSEcCtD
Vardenafil—Myalgia—Fluorouracil—colon cancer	0.00141	0.00256	CcSEcCtD
Vardenafil—Infection—Irinotecan—colon cancer	0.0014	0.00254	CcSEcCtD
Vardenafil—Hyperhidrosis—Vincristine—colon cancer	0.0014	0.00254	CcSEcCtD
Vardenafil—Hepatobiliary disease—Capecitabine—colon cancer	0.0014	0.00254	CcSEcCtD
Vardenafil—Epistaxis—Capecitabine—colon cancer	0.00139	0.00253	CcSEcCtD
Vardenafil—Discomfort—Fluorouracil—colon cancer	0.00139	0.00252	CcSEcCtD
Vardenafil—Shock—Irinotecan—colon cancer	0.00138	0.00252	CcSEcCtD
Vardenafil—Nervous system disorder—Irinotecan—colon cancer	0.00138	0.00251	CcSEcCtD
Vardenafil—Hyperhidrosis—Irinotecan—colon cancer	0.00136	0.00247	CcSEcCtD
Vardenafil—Hypotension—Vincristine—colon cancer	0.00135	0.00245	CcSEcCtD
Vardenafil—Anaphylactic shock—Fluorouracil—colon cancer	0.00135	0.00245	CcSEcCtD
Vardenafil—Infection—Fluorouracil—colon cancer	0.00134	0.00243	CcSEcCtD
Vardenafil—Haemoglobin—Capecitabine—colon cancer	0.00133	0.00242	CcSEcCtD
Vardenafil—Rhinitis—Capecitabine—colon cancer	0.00133	0.00242	CcSEcCtD
Vardenafil—Haemorrhage—Capecitabine—colon cancer	0.00133	0.00241	CcSEcCtD
Vardenafil—Nervous system disorder—Fluorouracil—colon cancer	0.00132	0.0024	CcSEcCtD
Vardenafil—Hypoaesthesia—Capecitabine—colon cancer	0.00132	0.0024	CcSEcCtD
Vardenafil—Liver function test abnormal—Methotrexate—colon cancer	0.00132	0.00239	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Vincristine—colon cancer	0.00132	0.00239	CcSEcCtD
Vardenafil—Pharyngitis—Capecitabine—colon cancer	0.00132	0.00239	CcSEcCtD
Vardenafil—Tachycardia—Fluorouracil—colon cancer	0.00131	0.00239	CcSEcCtD
Vardenafil—Hypotension—Irinotecan—colon cancer	0.00131	0.00239	CcSEcCtD
Vardenafil—Urinary tract disorder—Capecitabine—colon cancer	0.00131	0.00238	CcSEcCtD
Vardenafil—Insomnia—Vincristine—colon cancer	0.00131	0.00238	CcSEcCtD
Vardenafil—Connective tissue disorder—Capecitabine—colon cancer	0.0013	0.00237	CcSEcCtD
Vardenafil—Urethral disorder—Capecitabine—colon cancer	0.0013	0.00236	CcSEcCtD
Vardenafil—Paraesthesia—Vincristine—colon cancer	0.0013	0.00236	CcSEcCtD
Vardenafil—Breast disorder—Methotrexate—colon cancer	0.00129	0.00234	CcSEcCtD
Vardenafil—Visual impairment—Capecitabine—colon cancer	0.00128	0.00232	CcSEcCtD
Vardenafil—Insomnia—Irinotecan—colon cancer	0.00127	0.00231	CcSEcCtD
Vardenafil—Paraesthesia—Irinotecan—colon cancer	0.00126	0.0023	CcSEcCtD
Vardenafil—Hypotension—Fluorouracil—colon cancer	0.00126	0.00229	CcSEcCtD
Vardenafil—Dyspnoea—Irinotecan—colon cancer	0.00125	0.00228	CcSEcCtD
Vardenafil—Somnolence—Irinotecan—colon cancer	0.00125	0.00227	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Vincristine—colon cancer	0.00125	0.00227	CcSEcCtD
Vardenafil—Eye disorder—Capecitabine—colon cancer	0.00124	0.00225	CcSEcCtD
Vardenafil—Dyspepsia—Irinotecan—colon cancer	0.00124	0.00225	CcSEcCtD
Vardenafil—Tinnitus—Capecitabine—colon cancer	0.00124	0.00225	CcSEcCtD
Vardenafil—Pain—Vincristine—colon cancer	0.00124	0.00225	CcSEcCtD
Vardenafil—Cardiac disorder—Capecitabine—colon cancer	0.00123	0.00224	CcSEcCtD
Vardenafil—Flushing—Capecitabine—colon cancer	0.00123	0.00224	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00123	0.00223	CcSEcCtD
Vardenafil—Insomnia—Fluorouracil—colon cancer	0.00122	0.00222	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Irinotecan—colon cancer	0.00121	0.00221	CcSEcCtD
Vardenafil—Paraesthesia—Fluorouracil—colon cancer	0.00121	0.0022	CcSEcCtD
Vardenafil—Pain—Irinotecan—colon cancer	0.0012	0.00219	CcSEcCtD
Vardenafil—Angiopathy—Capecitabine—colon cancer	0.0012	0.00219	CcSEcCtD
Vardenafil—Dyspnoea—Fluorouracil—colon cancer	0.0012	0.00218	CcSEcCtD
Vardenafil—Somnolence—Fluorouracil—colon cancer	0.0012	0.00218	CcSEcCtD
Vardenafil—Immune system disorder—Capecitabine—colon cancer	0.0012	0.00218	CcSEcCtD
Vardenafil—Mediastinal disorder—Capecitabine—colon cancer	0.00119	0.00217	CcSEcCtD
Vardenafil—Dyspepsia—Fluorouracil—colon cancer	0.00119	0.00216	CcSEcCtD
Vardenafil—Gastrointestinal pain—Vincristine—colon cancer	0.00118	0.00215	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00116	0.00211	CcSEcCtD
Vardenafil—Mental disorder—Capecitabine—colon cancer	0.00116	0.00211	CcSEcCtD
Vardenafil—Feeling abnormal—Irinotecan—colon cancer	0.00116	0.00211	CcSEcCtD
Vardenafil—Erythema—Capecitabine—colon cancer	0.00115	0.0021	CcSEcCtD
Vardenafil—Pain—Fluorouracil—colon cancer	0.00115	0.00209	CcSEcCtD
Vardenafil—Gastrointestinal pain—Irinotecan—colon cancer	0.00115	0.00209	CcSEcCtD
Vardenafil—Abdominal pain—Vincristine—colon cancer	0.00114	0.00208	CcSEcCtD
Vardenafil—Photosensitivity reaction—Methotrexate—colon cancer	0.00113	0.00205	CcSEcCtD
Vardenafil—Back pain—Capecitabine—colon cancer	0.00112	0.00203	CcSEcCtD
Vardenafil—Abdominal pain—Irinotecan—colon cancer	0.00111	0.00202	CcSEcCtD
Vardenafil—Feeling abnormal—Fluorouracil—colon cancer	0.00111	0.00202	CcSEcCtD
Vardenafil—Muscle spasms—Capecitabine—colon cancer	0.00111	0.00202	CcSEcCtD
Vardenafil—Infestation—Methotrexate—colon cancer	0.0011	0.002	CcSEcCtD
Vardenafil—Infestation NOS—Methotrexate—colon cancer	0.0011	0.002	CcSEcCtD
Vardenafil—Vision blurred—Capecitabine—colon cancer	0.00109	0.00198	CcSEcCtD
Vardenafil—Ill-defined disorder—Capecitabine—colon cancer	0.00107	0.00195	CcSEcCtD
Vardenafil—Conjunctivitis—Methotrexate—colon cancer	0.00107	0.00194	CcSEcCtD
Vardenafil—Hypersensitivity—Vincristine—colon cancer	0.00106	0.00193	CcSEcCtD
Vardenafil—Sweating—Methotrexate—colon cancer	0.00105	0.00192	CcSEcCtD
Vardenafil—Haematuria—Methotrexate—colon cancer	0.00105	0.00191	CcSEcCtD
Vardenafil—Malaise—Capecitabine—colon cancer	0.00104	0.00189	CcSEcCtD
Vardenafil—Hepatobiliary disease—Methotrexate—colon cancer	0.00104	0.00189	CcSEcCtD
Vardenafil—Epistaxis—Methotrexate—colon cancer	0.00104	0.00188	CcSEcCtD
Vardenafil—Vertigo—Capecitabine—colon cancer	0.00104	0.00188	CcSEcCtD
Vardenafil—Hypersensitivity—Irinotecan—colon cancer	0.00104	0.00188	CcSEcCtD
Vardenafil—Asthenia—Vincristine—colon cancer	0.00104	0.00188	CcSEcCtD
Vardenafil—Syncope—Capecitabine—colon cancer	0.00103	0.00188	CcSEcCtD
Vardenafil—Palpitations—Capecitabine—colon cancer	0.00102	0.00185	CcSEcCtD
Vardenafil—Loss of consciousness—Capecitabine—colon cancer	0.00101	0.00184	CcSEcCtD
Vardenafil—Asthenia—Irinotecan—colon cancer	0.00101	0.00184	CcSEcCtD
Vardenafil—Hypersensitivity—Fluorouracil—colon cancer	0.000993	0.0018	CcSEcCtD
Vardenafil—Haemoglobin—Methotrexate—colon cancer	0.000992	0.0018	CcSEcCtD
Vardenafil—Diarrhoea—Vincristine—colon cancer	0.000988	0.0018	CcSEcCtD
Vardenafil—Haemorrhage—Methotrexate—colon cancer	0.000987	0.00179	CcSEcCtD
Vardenafil—Myalgia—Capecitabine—colon cancer	0.000982	0.00179	CcSEcCtD
Vardenafil—Chest pain—Capecitabine—colon cancer	0.000982	0.00179	CcSEcCtD
Vardenafil—Arthralgia—Capecitabine—colon cancer	0.000982	0.00179	CcSEcCtD
Vardenafil—Pharyngitis—Methotrexate—colon cancer	0.000979	0.00178	CcSEcCtD
Vardenafil—Anxiety—Capecitabine—colon cancer	0.000979	0.00178	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000975	0.00177	CcSEcCtD
Vardenafil—Urinary tract disorder—Methotrexate—colon cancer	0.000974	0.00177	CcSEcCtD
Vardenafil—Discomfort—Capecitabine—colon cancer	0.00097	0.00176	CcSEcCtD
Vardenafil—Urethral disorder—Methotrexate—colon cancer	0.000967	0.00176	CcSEcCtD
Vardenafil—Diarrhoea—Irinotecan—colon cancer	0.000963	0.00175	CcSEcCtD
Vardenafil—Dry mouth—Capecitabine—colon cancer	0.000961	0.00175	CcSEcCtD
Vardenafil—Dizziness—Vincristine—colon cancer	0.000955	0.00174	CcSEcCtD
Vardenafil—Pruritus—Fluorouracil—colon cancer	0.000953	0.00173	CcSEcCtD
Vardenafil—Visual impairment—Methotrexate—colon cancer	0.000951	0.00173	CcSEcCtD
Vardenafil—Infection—Capecitabine—colon cancer	0.000935	0.0017	CcSEcCtD
Vardenafil—Dizziness—Irinotecan—colon cancer	0.00093	0.00169	CcSEcCtD
Vardenafil—Shock—Capecitabine—colon cancer	0.000926	0.00168	CcSEcCtD
Vardenafil—Nervous system disorder—Capecitabine—colon cancer	0.000923	0.00168	CcSEcCtD
Vardenafil—Eye disorder—Methotrexate—colon cancer	0.000922	0.00168	CcSEcCtD
Vardenafil—Diarrhoea—Fluorouracil—colon cancer	0.000922	0.00168	CcSEcCtD
Vardenafil—Tinnitus—Methotrexate—colon cancer	0.00092	0.00167	CcSEcCtD
Vardenafil—Tachycardia—Capecitabine—colon cancer	0.000919	0.00167	CcSEcCtD
Vardenafil—Vomiting—Vincristine—colon cancer	0.000918	0.00167	CcSEcCtD
Vardenafil—Cardiac disorder—Methotrexate—colon cancer	0.000916	0.00166	CcSEcCtD
Vardenafil—Skin disorder—Capecitabine—colon cancer	0.000915	0.00166	CcSEcCtD
Vardenafil—Rash—Vincristine—colon cancer	0.000911	0.00166	CcSEcCtD
Vardenafil—Hyperhidrosis—Capecitabine—colon cancer	0.00091	0.00165	CcSEcCtD
Vardenafil—Dermatitis—Vincristine—colon cancer	0.00091	0.00165	CcSEcCtD
Vardenafil—Headache—Vincristine—colon cancer	0.000905	0.00165	CcSEcCtD
Vardenafil—Angiopathy—Methotrexate—colon cancer	0.000895	0.00163	CcSEcCtD
Vardenafil—Vomiting—Irinotecan—colon cancer	0.000894	0.00163	CcSEcCtD
Vardenafil—Immune system disorder—Methotrexate—colon cancer	0.000891	0.00162	CcSEcCtD
Vardenafil—Dizziness—Fluorouracil—colon cancer	0.000891	0.00162	CcSEcCtD
Vardenafil—Mediastinal disorder—Methotrexate—colon cancer	0.000889	0.00162	CcSEcCtD
Vardenafil—Rash—Irinotecan—colon cancer	0.000887	0.00161	CcSEcCtD
Vardenafil—Dermatitis—Irinotecan—colon cancer	0.000886	0.00161	CcSEcCtD
Vardenafil—Headache—Irinotecan—colon cancer	0.000881	0.0016	CcSEcCtD
Vardenafil—Hypotension—Capecitabine—colon cancer	0.00088	0.0016	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—colon cancer	0.000864	0.00157	CcSEcCtD
Vardenafil—Erythema—Methotrexate—colon cancer	0.000859	0.00156	CcSEcCtD
Vardenafil—Nausea—Vincristine—colon cancer	0.000858	0.00156	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000858	0.00156	CcSEcCtD
Vardenafil—Vomiting—Fluorouracil—colon cancer	0.000857	0.00156	CcSEcCtD
Vardenafil—Insomnia—Capecitabine—colon cancer	0.000852	0.00155	CcSEcCtD
Vardenafil—Rash—Fluorouracil—colon cancer	0.00085	0.00154	CcSEcCtD
Vardenafil—Dermatitis—Fluorouracil—colon cancer	0.000849	0.00154	CcSEcCtD
Vardenafil—Paraesthesia—Capecitabine—colon cancer	0.000845	0.00154	CcSEcCtD
Vardenafil—Headache—Fluorouracil—colon cancer	0.000844	0.00153	CcSEcCtD
Vardenafil—Dyspnoea—Capecitabine—colon cancer	0.000839	0.00153	CcSEcCtD
Vardenafil—Nausea—Irinotecan—colon cancer	0.000836	0.00152	CcSEcCtD
Vardenafil—Back pain—Methotrexate—colon cancer	0.000831	0.00151	CcSEcCtD
Vardenafil—Dyspepsia—Capecitabine—colon cancer	0.000829	0.00151	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Capecitabine—colon cancer	0.000813	0.00148	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—colon cancer	0.000809	0.00147	CcSEcCtD
Vardenafil—Pain—Capecitabine—colon cancer	0.000805	0.00146	CcSEcCtD
Vardenafil—Nausea—Fluorouracil—colon cancer	0.0008	0.00146	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—colon cancer	0.000797	0.00145	CcSEcCtD
Vardenafil—Feeling abnormal—Capecitabine—colon cancer	0.000776	0.00141	CcSEcCtD
Vardenafil—Malaise—Methotrexate—colon cancer	0.000774	0.00141	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—colon cancer	0.000772	0.0014	CcSEcCtD
Vardenafil—Gastrointestinal pain—Capecitabine—colon cancer	0.00077	0.0014	CcSEcCtD
Vardenafil—Abdominal pain—Capecitabine—colon cancer	0.000744	0.00135	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—colon cancer	0.000744	0.00135	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—colon cancer	0.000731	0.00133	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—colon cancer	0.000731	0.00133	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—colon cancer	0.000731	0.00133	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000726	0.00132	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—colon cancer	0.000722	0.00131	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—colon cancer	0.000701	0.00127	CcSEcCtD
Vardenafil—Infection—Methotrexate—colon cancer	0.000696	0.00127	CcSEcCtD
Vardenafil—Hypersensitivity—Capecitabine—colon cancer	0.000694	0.00126	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—colon cancer	0.000687	0.00125	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—colon cancer	0.000681	0.00124	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—colon cancer	0.000678	0.00123	CcSEcCtD
Vardenafil—Asthenia—Capecitabine—colon cancer	0.000676	0.00123	CcSEcCtD
Vardenafil—Pruritus—Capecitabine—colon cancer	0.000666	0.00121	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—colon cancer	0.000655	0.00119	CcSEcCtD
Vardenafil—Diarrhoea—Capecitabine—colon cancer	0.000644	0.00117	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000639	0.00116	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—colon cancer	0.000634	0.00115	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—colon cancer	0.000629	0.00114	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—colon cancer	0.000625	0.00114	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—colon cancer	0.000623	0.00113	CcSEcCtD
Vardenafil—Dizziness—Capecitabine—colon cancer	0.000623	0.00113	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—colon cancer	0.000617	0.00112	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000605	0.0011	CcSEcCtD
Vardenafil—Pain—Methotrexate—colon cancer	0.000599	0.00109	CcSEcCtD
Vardenafil—Vomiting—Capecitabine—colon cancer	0.000599	0.00109	CcSEcCtD
Vardenafil—Rash—Capecitabine—colon cancer	0.000594	0.00108	CcSEcCtD
Vardenafil—Dermatitis—Capecitabine—colon cancer	0.000593	0.00108	CcSEcCtD
Vardenafil—Headache—Capecitabine—colon cancer	0.00059	0.00107	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—colon cancer	0.000578	0.00105	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—colon cancer	0.000573	0.00104	CcSEcCtD
Vardenafil—Nausea—Capecitabine—colon cancer	0.000559	0.00102	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—colon cancer	0.000554	0.00101	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—colon cancer	0.000516	0.000939	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—colon cancer	0.000503	0.000914	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—colon cancer	0.000496	0.000902	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—colon cancer	0.00048	0.000872	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—colon cancer	0.000463	0.000843	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—colon cancer	0.000446	0.00081	CcSEcCtD
Vardenafil—Rash—Methotrexate—colon cancer	0.000442	0.000804	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—colon cancer	0.000442	0.000803	CcSEcCtD
Vardenafil—Headache—Methotrexate—colon cancer	0.000439	0.000798	CcSEcCtD
Vardenafil—Nausea—Methotrexate—colon cancer	0.000416	0.000757	CcSEcCtD
Vardenafil—PDE10A—Hemostasis—NRAS—colon cancer	0.000158	0.00261	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—PIK3CA—colon cancer	0.000157	0.0026	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—KRAS—colon cancer	0.000156	0.00259	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—PIK3CA—colon cancer	0.000156	0.00259	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—KRAS—colon cancer	0.000156	0.00258	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—PIK3CA—colon cancer	0.000156	0.00258	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—HRAS—colon cancer	0.000155	0.00257	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—KRAS—colon cancer	0.000152	0.00252	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—AKT1—colon cancer	0.000152	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—CASP3—colon cancer	0.00015	0.00249	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	0.000149	0.00247	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TGFB1—colon cancer	0.000146	0.00243	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TGFB1—colon cancer	0.000146	0.00243	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—PIK3CA—colon cancer	0.000146	0.00242	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—PIK3CA—colon cancer	0.000146	0.00242	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—HRAS—colon cancer	0.000146	0.00242	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—HRAS—colon cancer	0.000145	0.00241	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—PIK3CA—colon cancer	0.000145	0.0024	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—HRAS—colon cancer	0.000145	0.0024	CbGpPWpGaD
Vardenafil—PDE6G—Disease—FGFR3—colon cancer	0.000144	0.00239	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—HRAS—colon cancer	0.000144	0.00238	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—PIK3CA—colon cancer	0.000144	0.00238	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—PIK3CA—colon cancer	0.000143	0.00237	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—CDKN1A—colon cancer	0.000142	0.00235	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	0.000141	0.00234	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—PIK3CA—colon cancer	0.00014	0.00232	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2L1—colon cancer	0.000139	0.0023	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—AKT1—colon cancer	0.000137	0.00227	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—KRAS—colon cancer	0.000136	0.00225	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—KRAS—colon cancer	0.000136	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—HRAS—colon cancer	0.000135	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—HRAS—colon cancer	0.000135	0.00224	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—colon cancer	0.000135	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—HRAS—colon cancer	0.000134	0.00222	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—HRAS—colon cancer	0.000133	0.0022	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FGFR3—colon cancer	0.000133	0.0022	CbGpPWpGaD
Vardenafil—PDE6G—Disease—APC—colon cancer	0.000133	0.0022	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—HRAS—colon cancer	0.000132	0.00219	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—SRC—colon cancer	0.000131	0.00217	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	0.00013	0.00215	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—HRAS—colon cancer	0.000129	0.00214	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—AKT1—colon cancer	0.000129	0.00214	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—AKT1—colon cancer	0.000128	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—AKT1—colon cancer	0.000128	0.00212	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—AKT1—colon cancer	0.000127	0.00211	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—NRAS—colon cancer	0.000126	0.00209	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—PIK3CA—colon cancer	0.000125	0.00206	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—PIK3CA—colon cancer	0.000125	0.00206	CbGpPWpGaD
Vardenafil—PDE6G—Disease—BRAF—colon cancer	0.000125	0.00206	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—colon cancer	0.000121	0.002	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—colon cancer	0.000121	0.002	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	0.00012	0.00199	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—AKT1—colon cancer	0.00012	0.00198	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—AKT1—colon cancer	0.00012	0.00198	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—AKT1—colon cancer	0.000118	0.00196	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000117	0.00195	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—AKT1—colon cancer	0.000117	0.00194	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—HRAS—colon cancer	0.000115	0.00191	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—HRAS—colon cancer	0.000115	0.00191	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—EGFR—colon cancer	0.000115	0.0019	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ODC1—colon cancer	0.000115	0.0019	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CHST5—colon cancer	0.000115	0.0019	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—AKT1—colon cancer	0.000114	0.00189	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGFR3—colon cancer	0.000111	0.00183	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—KRAS—colon cancer	0.000108	0.0018	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	0.000106	0.00175	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—AKT1—colon cancer	0.000102	0.00169	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—AKT1—colon cancer	0.000102	0.00169	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—APC—colon cancer	0.000101	0.00168	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—NRAS—colon cancer	0.000101	0.00168	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGFR3—colon cancer	0.000101	0.00167	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTGS2—colon cancer	0.000101	0.00167	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—PIK3CA—colon cancer	9.97e-05	0.00165	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGFR3—colon cancer	9.85e-05	0.00163	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—BRAF—colon cancer	9.54e-05	0.00158	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD8A—colon cancer	9.44e-05	0.00156	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—APC—colon cancer	9.28e-05	0.00154	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EGFR—colon cancer	9.24e-05	0.00153	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—HRAS—colon cancer	9.22e-05	0.00153	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—APC—colon cancer	9.04e-05	0.0015	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—NRAS—colon cancer	9.04e-05	0.0015	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CTNNB1—colon cancer	9e-05	0.00149	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—PIK3CA—colon cancer	8.84e-05	0.00146	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN1A—colon cancer	8.79e-05	0.00146	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA7—colon cancer	8.79e-05	0.00146	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—KRAS—colon cancer	8.73e-05	0.00145	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—BRAF—colon cancer	8.72e-05	0.00145	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—EP300—colon cancer	8.54e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—BRAF—colon cancer	8.5e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EP300—colon cancer	8.37e-05	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SRC—colon cancer	8.3e-05	0.00138	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CTNNB1—colon cancer	8.27e-05	0.00137	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EGFR—colon cancer	8.24e-05	0.00137	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—colon cancer	8.14e-05	0.00135	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SRC—colon cancer	8.14e-05	0.00135	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—colon cancer	8.09e-05	0.00134	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CDKN1A—colon cancer	8.08e-05	0.00134	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2L1—colon cancer	8.08e-05	0.00134	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PIK3CA—colon cancer	8.02e-05	0.00133	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NRAS—colon cancer	7.99e-05	0.00132	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—PIK3CA—colon cancer	7.87e-05	0.0013	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NRAS—colon cancer	7.83e-05	0.0013	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—KRAS—colon cancer	7.78e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGFR3—colon cancer	7.72e-05	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EP300—colon cancer	7.69e-05	0.00127	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—SRC—colon cancer	7.47e-05	0.00124	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HRAS—colon cancer	7.42e-05	0.00123	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—colon cancer	7.42e-05	0.00123	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—colon cancer	7.29e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—colon cancer	7.27e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—colon cancer	7.22e-05	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—NRAS—colon cancer	7.19e-05	0.00119	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PIK3CA—colon cancer	7.15e-05	0.00118	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CASP3—colon cancer	7.15e-05	0.00118	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—colon cancer	7.13e-05	0.00118	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGFR3—colon cancer	7.13e-05	0.00118	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCND1—colon cancer	6.96e-05	0.00115	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CTNNB1—colon cancer	6.89e-05	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—KRAS—colon cancer	6.87e-05	0.00114	CbGpPWpGaD
Vardenafil—PDE6G—Disease—KRAS—colon cancer	6.74e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1A—colon cancer	6.73e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HRAS—colon cancer	6.62e-05	0.0011	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—colon cancer	6.55e-05	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—colon cancer	6.55e-05	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APC—colon cancer	6.55e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CASP3—colon cancer	6.54e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDH1—colon cancer	6.52e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—colon cancer	6.43e-05	0.00107	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EP300—colon cancer	6.41e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CASP3—colon cancer	6.37e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCND1—colon cancer	6.37e-05	0.00105	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PIK3CA—colon cancer	6.32e-05	0.00105	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CTNNB1—colon cancer	6.3e-05	0.00104	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SRC—colon cancer	6.23e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCND1—colon cancer	6.2e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PIK3CA—colon cancer	6.19e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—KRAS—colon cancer	6.19e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1A—colon cancer	6.16e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BRAF—colon cancer	6.15e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CTNNB1—colon cancer	6.14e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—colon cancer	6.11e-05	0.00101	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—colon cancer	6.07e-05	0.00101	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1A—colon cancer	6e-05	0.000994	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NRAS—colon cancer	5.99e-05	0.000993	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EP300—colon cancer	5.86e-05	0.000971	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—HRAS—colon cancer	5.84e-05	0.000968	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—colon cancer	5.84e-05	0.000968	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HRAS—colon cancer	5.73e-05	0.000949	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EP300—colon cancer	5.71e-05	0.000946	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SRC—colon cancer	5.7e-05	0.000944	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—colon cancer	5.69e-05	0.000942	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—colon cancer	5.58e-05	0.000925	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—colon cancer	5.57e-05	0.000923	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SRC—colon cancer	5.55e-05	0.00092	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—colon cancer	5.55e-05	0.00092	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NRAS—colon cancer	5.48e-05	0.000908	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—colon cancer	5.46e-05	0.000905	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—colon cancer	5.41e-05	0.000896	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NRAS—colon cancer	5.34e-05	0.000885	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ODC1—colon cancer	5.33e-05	0.000883	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CHST5—colon cancer	5.33e-05	0.000883	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—HRAS—colon cancer	5.26e-05	0.000871	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—colon cancer	5.16e-05	0.000855	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KRAS—colon cancer	5.16e-05	0.000855	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—colon cancer	5.11e-05	0.000846	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—colon cancer	5.09e-05	0.000844	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—colon cancer	5.06e-05	0.000838	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—colon cancer	4.99e-05	0.000827	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGFR3—colon cancer	4.99e-05	0.000827	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—colon cancer	4.98e-05	0.000824	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—colon cancer	4.97e-05	0.000823	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—colon cancer	4.96e-05	0.000822	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—colon cancer	4.87e-05	0.000806	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTNNB1—colon cancer	4.82e-05	0.000798	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—colon cancer	4.74e-05	0.000785	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KRAS—colon cancer	4.72e-05	0.000782	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1A—colon cancer	4.7e-05	0.000779	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—colon cancer	4.64e-05	0.000769	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KRAS—colon cancer	4.6e-05	0.000762	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—colon cancer	4.59e-05	0.00076	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APC—colon cancer	4.58e-05	0.000759	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—NRAS—colon cancer	4.58e-05	0.000759	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EP300—colon cancer	4.48e-05	0.000742	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CTNNB1—colon cancer	4.45e-05	0.000737	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HRAS—colon cancer	4.39e-05	0.000726	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SRC—colon cancer	4.35e-05	0.000721	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1A—colon cancer	4.34e-05	0.00072	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—colon cancer	4.33e-05	0.000718	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BRAF—colon cancer	4.31e-05	0.000714	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—colon cancer	4.22e-05	0.0007	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—colon cancer	4.19e-05	0.000695	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NRAS—colon cancer	4.19e-05	0.000694	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—colon cancer	4.18e-05	0.000692	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EP300—colon cancer	4.13e-05	0.000685	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—colon cancer	4.09e-05	0.000677	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SRC—colon cancer	4.02e-05	0.000666	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HRAS—colon cancer	4.01e-05	0.000664	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—colon cancer	3.99e-05	0.000661	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—KRAS—colon cancer	3.94e-05	0.000654	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HRAS—colon cancer	3.91e-05	0.000648	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—colon cancer	3.87e-05	0.000641	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NRAS—colon cancer	3.87e-05	0.000641	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—colon cancer	3.82e-05	0.000632	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—colon cancer	3.62e-05	0.0006	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KRAS—colon cancer	3.6e-05	0.000597	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—colon cancer	3.6e-05	0.000597	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—colon cancer	3.59e-05	0.000595	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—colon cancer	3.54e-05	0.000587	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—colon cancer	3.52e-05	0.000584	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—colon cancer	3.45e-05	0.000572	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HRAS—colon cancer	3.35e-05	0.000556	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KRAS—colon cancer	3.33e-05	0.000551	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—colon cancer	3.31e-05	0.000549	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—colon cancer	3.26e-05	0.00054	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—colon cancer	3.23e-05	0.000535	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—colon cancer	3.14e-05	0.000521	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CTNNB1—colon cancer	3.11e-05	0.000516	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HRAS—colon cancer	3.06e-05	0.000508	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—colon cancer	3.06e-05	0.000507	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1A—colon cancer	3.04e-05	0.000504	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCB1—colon cancer	3.03e-05	0.000502	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TYMS—colon cancer	2.97e-05	0.000493	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—colon cancer	2.96e-05	0.000491	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EP300—colon cancer	2.89e-05	0.00048	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HRAS—colon cancer	2.83e-05	0.000469	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SRC—colon cancer	2.81e-05	0.000466	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—colon cancer	2.74e-05	0.000454	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NRAS—colon cancer	2.71e-05	0.000449	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—colon cancer	2.71e-05	0.000448	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—colon cancer	2.52e-05	0.000418	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—colon cancer	2.52e-05	0.000417	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—colon cancer	2.5e-05	0.000414	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—colon cancer	2.47e-05	0.000409	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KRAS—colon cancer	2.33e-05	0.000386	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—colon cancer	2.14e-05	0.000355	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—colon cancer	2.11e-05	0.000349	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—colon cancer	2.07e-05	0.000343	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HRAS—colon cancer	1.98e-05	0.000328	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—colon cancer	1.75e-05	0.00029	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—colon cancer	1.66e-05	0.000275	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCB1—colon cancer	1.41e-05	0.000233	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TYMS—colon cancer	1.38e-05	0.000229	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—EP300—colon cancer	1.38e-05	0.000228	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—colon cancer	1.02e-05	0.000169	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—colon cancer	9.79e-06	0.000162	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—colon cancer	8.33e-06	0.000138	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—colon cancer	7.7e-06	0.000128	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—EP300—colon cancer	6.41e-06	0.000106	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—colon cancer	4.74e-06	7.85e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—colon cancer	3.87e-06	6.42e-05	CbGpPWpGaD
